Influvac

Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Vic, the active ingredient in Influvac, is a vaccine presented as an injectable solution for intramuscular or subcutaneous use. It is intended to prevent influenza caused by influenza A and B viruses in individuals at risk, including adults and children.

GNH USA supplies Influvac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for vaccine global distribution.

Influvac is an influenza vaccine used to stimulate immunity against seasonal influenza viruses. - Seasonal influenza: reduces the risk of infection with circulating influenza A and B strains. - Influenza outbreaks: provides protective immunity to help control community spread. - High‑risk populations: lowers the likelihood of severe disease and complications in elderly, pregnant persons, and individuals with chronic conditions.

Like all vaccines, Influvac may be associated with adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain, redness or swelling. - Low‑grade fever. - Headache. - Muscle aches (myalgia). - Fatigue. - Nausea.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Guillain‑Barré syndrome. - High fever or seizures. - Severe local reaction with extensive swelling. - Thrombocytopenia or bleeding disorders.

Prior to administration, healthcare providers should evaluate the following precautions to ensure safe use of Influvac. - Contraindication: known severe allergy to any vaccine component or previous severe reaction to influenza vaccine. - Delay vaccination: postpone if the patient has an acute febrile illness until recovery. - Monitoring: observe the patient for at least 15 minutes after injection for signs of allergic reaction. - Pregnancy: consider vaccination if benefits outweigh potential risks; consult a healthcare professional. - Egg allergy: exercise caution in individuals with severe egg protein hypersensitivity, as trace amounts may be present. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Influvac may interact with certain medical conditions or therapies that affect immune response.

Major Interactions (Avoid): - Live attenuated vaccines: avoid simultaneous administration; schedule at least 4 weeks apart. - Severe immunosuppression (e.g., high‑dose chemotherapy): vaccine may be ineffective and is generally contraindicated.

Moderate Interactions (Monitor Closely): - Moderate immunosuppressive therapy (e.g., low‑dose steroids): may reduce antibody response, monitor serology if needed. - Antiviral medications (e.g., oseltamivir) taken around vaccination: no major effect, but timing can be coordinated. - Chronic illnesses (e.g., uncontrolled diabetes): monitor for heightened reactogenicity.